Home › Funds › Prosight Management, LP › CRBP
Prosight Management, LP position in CRBP
CORBUS PHARMACEUTICALS HLDGS · Health Care
Prosight Management, LP reported holding 168,383 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.22% of its reported portfolio and ranking #30 among its reported holdings. Prosight Management, LP has disclosed CRBP holdings in 10 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Prosight Management, LP's CRBP position evolved
Prosight Management, LP first disclosed a stake in CRBP in Q1 2024 at 100,617 shares (US$3.9M). The position peaked in Q1 2026 at 697,108 shares, worth US$6.5M. Across 10 filings, Prosight Management, LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 168,383 shares valued at US$1.1M — a reduction of -481,617 shares quarter over quarter.. Notable position changes include a 108% increase in Q4 2024 (shares fell 55% over the following quarter), a 113% increase in Q1 2025 (shares rose 30% over the following quarter), a 99% increase in Q4 2025 (shares rose 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 100.62K | $3.95M | New |
| Q3 2024 | 130.00K | $2.68M | New |
| Q4 2024 | 270.00K | $3.19M | Add |
| Q1 2025 | 575.14K | $3.05M | Add |
| Q2 2025 | 579.89K | $4.00M | Add |
| Q3 2025 | 343.40K | $4.34M | Reduce |
| Q4 2025 | 683.87K | $5.57M | Add |
| Q1 2026 | 697.11K | $6.55M | Add |
| Q2 2026 | 650.00K | $6.10M | Reduce |
| Q3 2026 | 168.38K | $1.15M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRBP and 13F data
CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 20 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$22.0M), Jones Hill Capital LP (US$6.0M), DIADEMA PARTNERS LP (US$2.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRBP
- Cormorant Asset Management, LP 2.34M sh · $22.00M · Q2 2026
- Jones Hill Capital LP 886.43K sh · $6.05M · Q3 2026
- DIADEMA PARTNERS LP 301.26K sh · $2.83M · Q2 2026
- Exome Asset Management LLC 184.91K sh · $1.73M · Q2 2026
More on Prosight Management, LP
FAQ
How long has Prosight Management, LP held CRBP?
Prosight Management, LP has disclosed CRBP holdings in 10 of the last 11 reported quarters, going back to Q1 2024.
What is Prosight Management, LP's current position in CRBP?
As of Q3 2026, Prosight Management, LP holds 168.38K shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $1.15M, representing 0.22% of its reported portfolio and ranking #30.
Has Prosight Management, LP been buying or selling CRBP?
In the latest 13F filing (Q3 2026), Prosight Management, LP reduced its position in CRBP. The position peaked in Q1 2026 at 697.11K shares.
Which other funds hold CRBP?
Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, DIADEMA PARTNERS LP, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.